HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Angélica Regina Cappellari Selected Research
Angélica Regina Cappellari Research Topics
Disease
6
Neoplasms (Cancer)
08/2022 - 01/2012
3
Urinary Bladder Neoplasms (Bladder Cancer)
08/2022 - 10/2013
2
Glioma (Gliomas)
01/2012 - 12/2008
1
Urinary Bladder Diseases (Bladder Diseases)
08/2022
1
Breast Neoplasms (Breast Cancer)
10/2021
1
Neoplasm Metastasis (Metastasis)
10/2021
1
Hyperalgesia
11/2020
1
Prostatic Neoplasms (Prostate Cancer)
01/2019
1
Carcinogenesis
10/2013
Drug/Important Bio-Agent (IBA)
6
Adenosine (Adenocard)
FDA Link
Generic
10/2021 - 12/2008
6
Enzymes
IBA
10/2021 - 12/2008
4
Adenosine Monophosphate (AMP)
IBA
10/2021 - 12/2008
4
5'-Nucleotidase (5' Nucleotidase)
IBA
03/2018 - 12/2008
3
Adenosine Triphosphate (ATP)
IBA
10/2021 - 01/2012
3
Nucleotides
IBA
10/2021 - 10/2013
2
Biomarkers (Surrogate Marker)
IBA
10/2021 - 03/2018
2
Biological Products
IBA
10/2021 - 01/2019
2
Adenine Nucleotides
IBA
10/2021 - 01/2019
2
Purinergic P1 Receptors (Adenosine Receptor)
IBA
11/2020 - 10/2013
2
Adenosine Diphosphate (ADP)
IBA
01/2019 - 01/2012
2
Proteins (Proteins, Gene)
FDA Link
01/2012 - 12/2008
2
adenylyl(3'-5')cytidine-3'-phosphate
IBA
01/2012 - 12/2008
1
Purinergic Receptors (Receptors, Purine)
IBA
08/2022
1
Apyrase (ATP Diphosphatase)
IBA
10/2021
1
Interleukin-6 (Interleukin 6)
IBA
11/2020
1
Opioid Analgesics (Opioids)
IBA
11/2020
1
Nerve Growth Factors (Neurotrophins)
IBA
11/2020
1
Morphine (MS Contin)
FDA Link
Generic
11/2020
1
Flavonoids
IBA
10/2013
1
Purine Nucleotides
IBA
10/2013
1
Quercetin
IBA
10/2013
1
Chondroitin Sulfates (Chondroitin Sulfate)
IBA
01/2012
1
Laminin (Merosin)
IBA
01/2012
1
Dipyridamole (Persantine)
FDA Link
Generic
01/2012
1
lipoarabinomannan (LAM)
IBA
01/2012
1
Adenosine Deaminase
IBA
01/2012
1
Purinergic P1 Receptor Antagonists
IBA
01/2012
1
Messenger RNA (mRNA)
IBA
12/2008
Therapy/Procedure
2
Radiotherapy
08/2022 - 03/2018
1
Aftercare (After-Treatment)
10/2021